MyLymphomaTeam

That sounds like an incredibly tough experience — going through the CAR-T process with Breyanzi (lisocabtagene maraleucel) only to have it not work as hoped takes real strength to face.

While specific member stories about restarting the CAR-T harvesting process aren't available here, this is something others in the DLBCL Show Full Answer

That sounds like an incredibly tough experience — going through the CAR-T process with Breyanzi (lisocabtagene maraleucel) only to have it not work as hoped takes real strength to face.

While specific member stories about restarting the CAR-T harvesting process aren't available here, this is something others in the DLBCL community have navigated. It may be worth posting your experience directly to MyLymphomaTeam to connect with members who've been through something similar. If Breyanzi didn't work, there are other options your oncologist may consider, including:

- Other CAR-T therapies like Yescarta (axicabtagene ciloleucel) or Kymriah (tisagenlecleucel)
- Bispecific antibodies like Epkinly (epcoritamab) or Columvi (glofitamab)
- Clinical trials exploring newer immunotherapy approaches

Each option carries its own risks and benefits, so a detailed conversation with your oncology team is really important to figure out the best next step for your specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

CAR T-Cell Therapy for Lymphoma: How Does It Work?

Early vs. Advanced DLBCL: How Are They Treated Differently?